Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies

US Patent 10376597 · Granted Aug 13, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Targeting tumor cells with chemotherapeutic agents conjugated to anti-matriptase2023
Use of multi-frequency impedance cytometry in conjunction with machine learning 2023
Markers for abnormal cells2019
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting tumor cells with chemotherapeutic agents conjugated to matriptase anti2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Targeting matriptase expressing tumor cells with chemotherapeutic agents conjuga2017
Specific delivery of toxins conjugated with antibodies to activate matripase2017